Alaimo Charles John

Avg. Two Year Performance

No purchase track record
47% Avg. Sale Return
21% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(3%)6%6%27%47%
Sale Success Rate9 of 1711 of 178 of 1712 of 1710 of 17

Aceto Corp.

Drugs » Drug Manufacturers - Major

Senior Vice President:

Holdings: 21.59K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--